Arbutus Biopharma Corp (ABUS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Arbutus Biopharma Corp, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -27.51x | -8.68x | -5.70x | -5.06x | -5.42x | -4.22x |
| P/B Ratio | 12.04x | 6.23x | 3.91x | 2.57x | 2.44x | 2.64x |
| P/S Ratio | 65.44x | 98.35x | 22.87x | 9.01x | 37.61x | 38.94x |
| Profitability | ||||||
| Gross Margin | 97.4% | 100.0% | 100.0% | 100.0% | 100.0% | -586.7% |
| Operating Margin | -192.1% | -1236.7% | -430.5% | -167.8% | -669.1% | -836.1% |
| Net Margin | -237.9% | -1133.0% | -401.6% | -178.0% | -693.9% | -922.0% |
| EBITDA Margin | -189.5% | -1108.5% | -391.3% | -158.5% | -652.0% | -835.3% |
| Liquidity | ||||||
| Current Ratio | 15.73x | 8.15x | 5.87x | 4.60x | 14.32x | 13.38x |
| Quick Ratio | 15.73x | 8.15x | 5.87x | 4.60x | 14.32x | 13.38x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.01x | 0.08x | 0.09x | 0.11x | 0.22x |
YoY = year-over-year change. Source: FMP..